U.S. Electric Utilities Stock News

Recent performance context CNO Financial Group (CNO) has drawn investor attention after recent trading, with the stock last closing at $47.91 and showing gains over the past week, month, and past 3 months. See our latest analysis for CNO Financial Group. That recent 1-day share price return of 1.68% sits within a broader trend, with a 90-day share price return of 15.33% and a 1-year total shareholder return of 26.21%, suggesting momentum has been building over time. If CNO's recent move has...

If you are wondering whether Vertiv Holdings Co at around US$300.51 is still priced reasonably after a huge run, you are asking the right question. The stock has pulled back recently, with the share price down 4.8% over the last week and 16.3% over the past month, even after very large 3 year and 5 year returns and a 160.8% return over the past year and 71.1% year to date. Recent headlines have focused on Vertiv's role in supporting power and thermal management infrastructure for data...

In late May 2026, Digital Realty Trust held its annual meeting, where shareholders rejected a proposal for enhanced water risk disclosure, while separately launching its London-based Digital Realty Innovation Lab that lets customers test AI and quantum technologies, including ORCA Computing’s photonic quantum systems, in live data center conditions. This combination of ESG-related shareholder pushback and a move into quantum-ready infrastructure highlights how Digital Realty is balancing...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

In early June 2026, Oppenheimer upgraded Iridium Communications, citing growing confidence in its role within the expanding satellite connectivity and communications services market. At the same time, a cluster of routine tax-related insider share withholdings and debate over Iridium’s high earnings multiple highlighted the tension between enthusiasm for its technology footprint and concerns about how fully expectations are already reflected in the share price. Next, we’ll explore how...

Limbach Holdings, Inc. recently participated in Stifel's Ninth Annual Boston Cross Sector 1x1 Conference at The InterContinental Boston, where President, CEO and Director Michael M. McCann presented the company’s story to investors. This investor-facing appearance offered management a platform to discuss Limbach’s evolving business mix, including its focus on higher-margin service relationships and energy-efficient building solutions. We’ll now look at how McCann’s conference appearance and...

What triggered the latest focus on Viper Energy Viper Energy (VNOM) has drawn fresh attention after first quarter 2026 results topped estimates, combined with a deal to acquire Riverbend Oil & Gas IX mineral and royalty interests and an increased 2026 production outlook. See our latest analysis for Viper Energy. The first quarter beat and Riverbend acquisition have come against a mixed backdrop, with the share price down 4.68% over the past month but still showing a 17.23% year to date share...

In late May 2026, Privia Health Group, Inc. signed a definitive agreement to enter the New Jersey market by partnering with the Neurology Group of Bergen County, a 25-clinician adult and pediatric neurology practice that will anchor Privia Medical Group, New Jersey and is expected to be on the Privia platform by year-end 2026. This partnership gives Privia a foothold in a new state while extending its interoperable technology and population health capabilities to community neurologists and...

AbbVie (ABBV) stock has been in focus after a series of recent drug approvals, including European clearance for Aquipta in acute migraine, an expanded EU label for Venclyxto in first-line CLL, and FDA approval of Decnupaz for BPDCN. See our latest analysis for AbbVie. Those approvals have arrived alongside firm share price momentum, with AbbVie’s 1 month share price return of 10.83% and 7 day share price return of 4.37% standing against a slightly weaker 90 day share price return and strong 5...

WEC Energy Group (WEC) drew investor attention after reporting first quarter 2026 earnings of $2.45 per share, which surpassed estimates, reaffirmed its 2026 outlook and underscored ongoing investment in natural gas and renewable projects. See our latest analysis for WEC Energy Group. The first quarter beat and reaffirmed outlook come after a mixed year for the stock, with the share price up 6.09% year to date but down over the past three months. The 5 year total shareholder return of 43.97%...

In May 2026, Icahn Enterprises L.P. reported first-quarter 2026 results showing revenues of US$2.20 billion, a GAAP net loss of US$459 million, and a US$201 million increase in Indicative Net Asset Value largely tied to gains in its CVI position. The Board also declared a quarterly distribution of US$0.50 per depositary unit, payable in cash or additional units, highlighting management’s continued emphasis on returning capital to unitholders despite reported losses. Next, we’ll consider how...

Why Verizon Communications (VZ) Is Back on Investors’ Radar Verizon Communications (VZ) has drawn fresh attention after recent share price moves, with the stock up 1.1% over the past day but down over the past week and month. For investors tracking longer stretches, Verizon shows a gain year to date and over the past year, set against a decline over the past 3 months. This creates a mixed backdrop for reassessing the telecom giant. See our latest analysis for Verizon Communications. With the...

In recent days, Provident Financial Services has benefited from a broader regional bank rally amid a stable, higher-for-longer interest rate backdrop that is supporting sector-wide net interest margins. Separately, Provident Bank’s appointment of Annamaria Vitelli as Executive Vice President, Chief Wealth Officer and President of Beacon Trust highlights a renewed push to grow its wealth management and fiduciary services franchise. We'll now examine how the sector-wide rate backdrop and...

EPR Properties recently presented at Nareit REITweek 2026 in New York, where President, CEO and Board Chair Gregory K. Silvers outlined the REIT’s focus on experiential real estate, including multiplex theaters. This update comes as domestic movie theaters are experiencing their strongest year since 2019, with significantly higher ticket sales supporting renewed interest in experiential assets. With theater ticket sales rebounding strongly, we’ll now assess how this demand backdrop may shape...

Granite Construction (GVA) has been active on multiple fronts this week, securing two construction contracts worth a combined US$60 million and closing a US$600 million senior notes offering that supplies additional funding capacity for upcoming work. See our latest analysis for Granite Construction. Those new contracts and the US$600 million senior notes sit against a strong backdrop, with the share price up 19.11% year to date and a 1 year total shareholder return of 54.54%, while the 5...

Event Overview and Recent Stock Moves West Pharmaceutical Services (WST) has drawn fresh attention after recent trading, with the stock closing at US$314.50. Short term performance has been mixed, with a 0.9% daily decline and a 2.6% slide over the past week. See our latest analysis for West Pharmaceutical Services. While the 1 day share price return is down 0.9% and the 7 day share price return is down 2.6%, the 90 day share price return of 27.9% and 1 year total shareholder return of 40.4%...

Ulta Beauty stock moves after recent performance shifts Ulta Beauty (ULTA) has drawn fresh investor attention after a period in which the stock declined around 13% over the past month and about 28% over the past 3 months. Those moves contrast with a roughly flat 1 year total return of about 0.3%. The 3 year and 5 year total returns, at about 10% and 38% respectively, highlight how timing has influenced shareholder outcomes. See our latest analysis for Ulta Beauty. At a share price of $467.07,...

In recent days, Morgan Stanley downgraded Chipotle Mexican Grill to Equal Weight and flagged that its sales drivers may be less compelling than some fast-food peers amid inflation, wage, and freight cost pressures. At the same time, Chipotle has continued pushing brand initiatives such as its “53 Years. 53 Real Ingredients” basketball-themed burrito giveaway, underscoring management’s focus on marketing and long-term expansion despite short-term caution from analysts. With the stock...

Recent performance context for Toro stock Toro (TTC) has drawn attention after the stock fell about 9% over the past month and about 12% over the past 3 months, even as its 1 year total return remains positive. See our latest analysis for Toro. With the share price at $87.21, the recent 1-month share price return of about 9% down and 3-month share price return of about 12% down contrast with a stronger 1-year total shareholder return of about 30%. This suggests momentum has faded even as...

Boeing and Riyadh Air recently announced that the new Saudi carrier’s first two 787 Dreamliners have been delivered to Riyadh, marking an early step toward a planned fleet of up to 72 aircraft serving more than 100 destinations by 2030. This delivery milestone underlines how Boeing’s widebody program is tied into Saudi Arabia’s broader aviation push to attract 150 million visitors and serve 330 million passengers annually by the end of the decade. Next, we’ll examine how the Riyadh Air 787...

Recent performance snapshot Micron Technology (MU) has drawn fresh attention after recent share price moves, with the stock down 13% over the past day and 11% over the past week, while remaining higher over the past month and the past 3 months. See our latest analysis for Micron Technology. The recent pullback comes after a powerful run, with the stock still showing a 174% year to date share price return and a very large 1 year total shareholder return. This suggests momentum is cooling...

If you are wondering whether DexCom at around US$72.86 is a bargain or a stock to be cautious about, the next step is to look closely at what that price might already be pricing in. The stock has risen 20.7% over the past month and is up 9.5% year to date, even though it is down 1.2% over the past week and has declined 15.9% over the last year and 41.4% over three years. Recent headlines around glucose monitoring, reimbursement policies and competition in medical devices help explain why...